Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

8.470 +0.430 (+5.35%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax Inc

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
60 61 Next >
Novavax Revenue Guidance Does Little to Change Neutral Stance on the Stock
NVAX stock's revenue guidance may have given investors a reason to stay invested. However, risks continue to outweigh benefits. 
Via InvestorPlace
10 Biggest Price Target Changes For Thursday
Piper Sandler cut the price target on Bright Health Group, Inc. (NYSE: BHG) from $10 to $5. Bright Health shares rose 3.2% to $2.59 in pre-market trading. 
Via Benzinga
Russia’s Aggression Could Put a Damper on Novavax Global Vax Deployment
The best chance for profits with NVAX stock is with the international market. But Russia's invasion of Ukraine could put Novavax's strategy at risk. 
Via InvestorPlace
44 Stocks Moving In Tuesday's Mid-Day Session
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) climbed 193% to $0.9962 after jumping 36% on Monday. GBS Inc. (NASDAQ: GBS) rose 73.3% to $0.7971 after declining around 9% on... 
Via Benzinga
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
Via Benzinga
Is Now The Time To Buy Stock In Novavax, Zoom Or Workhorse?
Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings b... 
Via Benzinga
What's Going On With Novavax Shares Today?
Novavax Inc (NASDAQ: NVAX) is trading higher Tuesday after the company reported fourth-quarter financial results and issued guidance expecting a surge in revenue. Novavax reported... 
Via Benzinga
Novavax Expects At Least $4 Billion In Covid Vaccine Sales This Year; Shares Pop
The company missed fourth-quarter expectations, however. 
Via Investor's Business Daily
27 Stocks Moving in Monday's Pre-Market Session
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 123.4% to $0.76 in pre-market trading after jumping 36% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) rose 28.6... 
Via Benzinga
My Top Things To Expect This Week
This week will bring earnings that give insight into multiple investment themes and other important events that you should watch out for. 
Via InvestorPlace
Novavax Stock’s Wild Moves Leave Little Room for Error
NVAX stock can still bring profits for traders and investors as long as they are willing to accept the risks that it brings. 
Via InvestorPlace
Why I’m Done With Novavax Stock
Management is terrible at delivering on its promises and even good news has failed to translate into higher prices for NVAX stock. 
Via InvestorPlace
Novavax: Q4 Earnings Insights
Novavax (NASDAQ:NVAX) reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Novavax... 
Via Benzinga
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... 
Via Benzinga
Moderna’s Covid Shot Alone Isn’t Enough to Revitalize a Sagging Stock
Moderna has to focus on the rest of its pipeline to keep MRNA stock relevant and profitable as Covid vaccine revenues taper off by 2023. 
Via InvestorPlace
Novavax: The Frustration Is Real, And So Is the Sales Potential
All isn't well with NVAX stock, but it is very close to rallying. The results could give Novavax a boost and push the stock high. 
Via InvestorPlace
Novavax Is a Buy on Recent Developments and Cheap Valuation
NVAX stock is one of the major players in the vaccine market, which is one that is expected to grow substantially over the next few years. 
Via InvestorPlace
4 Pharma Stocks to Buy Even if the Pandemic Ends
Here are four pharma stocks that looks attractive for the long-term. Deep product development pipelines will ensure steady revenue and cash flow growth. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Production Updates Could Give Novavax Stock a Big Boost
Given the low expectations for Novavax's deliveries, better-than-expected numbers could send the NVAX stock price back to the triple digits. 
Via InvestorPlace
Check Out What Whales Are Doing With NVAX
Someone with a lot of money to spend has taken a bearish stance on Novavax (NASDAQ:NVAX). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
After Being Unloved on Wall Street, Novavax Deserves a Shot
NVAX stock was a darling of the markets once and could be again, given Novavax's recent progress in advancing Covid-19 vaccines globally. 
Via InvestorPlace
Why Novavax Has Limited Downside from Here
As countries potentially adopt a once yearly vaccination booster schedule for Covid-19, you can expect steady earnings for NVAX stock. 
Via InvestorPlace
Dump Novavax Stock as Delays May Make Its Vaccine Practically Obsolete
NVAX stock's price continues to slide lower as the prospects of its Covid-19 vaccine getting approved in the U.S. grow dim. 
Via InvestorPlace
Novavax's COVID-19 Vaccine Scores Canadian Approval
Health Canada approves Novavax Inc's (NASDAQ: NVAX) Nuvaxovid COVID-19 Vaccine in individuals 18 years of age and older. The vaccine, also known as NVX-... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart
Macy's Inc (NYSE:M) retail stores have something for everyo... 
Via Benzinga
Novavax Stock Is at Risk Despite Positive Poll Results
A recent poll supports Novavax's Covid treatment in the United States, but the vote on today's NVAX stock price chart warns against buying. 
Via InvestorPlace
Novavax Just Can’t Get it Together
Patient investors will wait for NVAX stock to hit another low or for the FDA to approve its Covid-19 vaccine before investing. 
Via InvestorPlace
Novavax Stock Has Growth Ahead Whether It Missed the Boat or Not
NVAX stock has been derided as a ran in the vaccine race, avoid that narrative and remain optimistic because the best is ahead for Novavax. 
Via InvestorPlace
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
60 61 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.